Postal ballot results: 3 resolutions passed including MD reappointment

Board & Shareholder Meetings View source PDF Explain this filing

BALKRISIND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.7%Reaction day

₹2424.30

prior close

₹2437.00

announcement price

After-mkt

timing

Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)-1.7%+1.1% vs market

Tyres & Rubber Products peers, median of 15sector-1.6%+1.0% vs sector

On the reaction day the stock moved 1.1 pts more than Nifty Midcap 150 and 1.0 pts more than its Tyres & Rubber Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.0

10m

-0.8

15m

-0.9

30m

-1.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.7-1.7+1.1-1.6+1.0

Next day

-0.3-1.2+0.9-1.2+0.9

-0.9+0.4-1.3-0.5-0.4

-2.4+0.5-2.9-2.1-0.4

-4.9+0.5-5.5+0.4-5.3

-5.5-0.6-4.9-0.5-5.0

+10.7+2.9+7.8+1.0+9.7

15d

+7.0+2.8+4.2+1.7+5.4

+3.3+2.4+1.0+0.3+3.0

-15.9-9.0-6.8-10.5-5.3

-6.4+3.4-9.8-4.2-2.3

UpDownMarket · Nifty Midcap 150Sector · Tyres & Rubber Products peers, median of 15Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Shareholders approved 3 resolutions via postal ballot on 22 Jan 2026. Reappointment of Arvind Poddar as Chairman and Managing Director for 5 years from 1 August 2026 passed with 92.45 percent votes in favour. Appointment of Natarajan Gnanaskandan Tanjore as Independent Director got 99.95 percent support. Appointment of Ashok Saraf as Non-Executive Non-Independent Director passed with 99.90 percent votes in favour. All 3 resolutions cleared with requisite majority.

Likely market impact

Leadership continuity assured as Arvind Poddar continues as Chairman and MD. Two new directors onboarded to strengthen the board from 1 February 2026.